US$ 24.37
glp-1 receptor agonists muscle mass preservation 2025 Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Weight Reduction with GLP-1 Agonists
Description
Oztay F, Sancar-Bas S, Gezginci-Oktayoglu S, Ercin M, Bolkent S

Abbreviations CSII, continuous subcutaneous insulin infusion

Importantly, when GLP-1 therapy was combined with lifestyle changes, outcomes were stronger than either strategy alone

The 10 stocks that made the cut could produce monster returns in the coming years.

Similar benefits were observed for kidney disease progression alone and for a composite of ESKD and cardiovascular death
